186. "Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?" Michelle Fanale. Hematology Am Soc Hematol Educ Program 2013 (1): 406-413.
187. "Treatment of children and adolescents with early stage nodular lymphocyte predominant Hodgkin lymphoma with a low intensity short duration chemotherapy regimen (CVP)-on behalf of the EuroNet-PHL Group". Shankar et al. Blood, 2006, vol. 108 11pg. 2471
188. Optimizing Stem Cells Mobilization Strategies to Ameliorate Patient Outcomes: A Review of Guide- lines and Recommendations. Saeed Mohammadi, Ashraf Malek Mohammadi, Mohsen Nikbakht, Amir Hossein Norooznezhad, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Int J Hematol Oncol Stem Cell Res. 2017 Jan 1;11(1):78-88.
189."Stem cell mobilization and collection from pediatric patients and healthy children" Musa Karakukcu, Ekrem Unal. Transfusion and Apheresis Science, Volume 53, Issue 1, August 2015, Pages 17-22
190."Successful mobilization of peripheral blood stem cells in children with cancer using plerixafor (Mozobil) and granulocyte-colony stimulating factor" Boryana Avramova, Maya Yordanova, Dobrin Konstantinov, Dragan Bobev. Drug Des Devel Ther. 2011:5:407-9. Epub 2011 Aug 26.
191. Unal A, Sari I, Deniz K, Ozkan M, Kontas O, Eser B, Cetin M. Familial nodular lymphocyte predominant Hodgkin lymphoma: Successful treatment with CHOP plus rituximab. Leuk Lymphoma. 2005 Nov;46(11):1613-7. doi: 10.1080/10428190500236502. PMID: 16236615